ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,729,000 | -12.3% | 67,527 | +25.0% | 0.01% | 0.0% |
| Q2 2015 | $3,110,000 | +30.5% | 54,042 | +44.3% | 0.01% | +28.6% |
| Q1 2015 | $2,384,000 | +56.5% | 37,439 | +51.8% | 0.01% | +40.0% |
| Q4 2014 | $1,523,000 | +93.0% | 24,666 | +21.5% | 0.01% | +66.7% |
| Q3 2014 | $789,000 | +58.4% | 20,308 | +40.5% | 0.00% | +50.0% |
| Q2 2014 | $498,000 | -62.6% | 14,452 | -53.1% | 0.00% | -50.0% |
| Q1 2014 | $1,332,000 | +48.8% | 30,824 | +37.2% | 0.00% | +33.3% |
| Q4 2013 | $895,000 | +4.3% | 22,467 | -1.7% | 0.00% | 0.0% |
| Q3 2013 | $858,000 | +102.4% | 22,847 | +44.7% | 0.00% | +50.0% |
| Q2 2013 | $424,000 | – | 15,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |